OR WAIT null SECS
© 2021 MJH Life Sciences and Urology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
September 13, 2021
Magnetic resonance–guided focused ultrasound (MRgFUS) may be an effective alternative to radical therapy that improves outcomes for sexual function and urinary incontinence in men with intermediate-risk prostate cancer.
September 11, 2021
“The combination of TAR-200 and cetrelimab is being studied to determine whether it can improve patient outcomes,” says study coauthor Stephen B. Williams, MD, MS.
September 10, 2021
An analysis of three phase 3 trials highlighted the "obesity paradox" in prostate cancer.
March 10, 2021
The combination regimen shrank tumors and led to disease control in the majority of patients.